Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 7, 2007CarcinogenesisOpen Access

Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast

View Full Paper
Ask AI
Bookmark
Share

Authors

BCBrian S. CornblattNutramax Laboratories (United States)LYLingxiang YeZhejiang HospitalADAlbena T. Dinkova‐KostovaJohns Hopkins University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cornblatt et al. (2007) studied this question.

synapsesocial.com/papers/6a8980847fec28afabc11c24https://doi.org/10.1093/carcin/bgm049
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure.1992 · 1,690 citations
  2. 2Assessment of epidermal growth factor receptor (EGFR) signaling in paired colorectal cancer and normal colon tissue samples using computer-aided immunohistochemical analysis2005 · 41 citations
  3. 3Design and synthesis of bifunctional isothiocyanate analogs of sulforaphane: correlation between structure and potency as inducers of anticarcinogenic detoxication enzymes1994 · 159 citations
  4. 4Total intracellular accumulation levels of dietary isothiocyanates determine their activity in elevation of cellular glutathione and induction of Phase 2 detoxification enzymes2001 · 125 citations